Found: 13
Select item for more details and to access through your institution.
Efficacy and safety of escitalopram in treatment of severe depression in Chinese population.
- Published in:
- Metabolic Brain Disease, 2017, v. 32, n. 3, p. 891, doi. 10.1007/s11011-017-9992-5
- By:
- Publication type:
- Article
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2181, doi. 10.1007/s00277-023-05309-z
- By:
- Publication type:
- Article
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 12, p. 1689, doi. 10.1080/0284186X.2023.2254479
- By:
- Publication type:
- Article
Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with Schizophrenia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Suboptimal maternal diets alter mu opioid receptor and dopamine type 1 receptor binding but exert no effect on dopamine transporters in the offspring brain.
- Published in:
- International Journal of Developmental Neuroscience, 2018, v. 64, p. 21, doi. 10.1016/j.ijdevneu.2016.09.008
- By:
- Publication type:
- Article
Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double‐blind, placebo‐controlled study)
- Published in:
- Asia-Pacific Psychiatry, 2023, v. 15, n. 4, p. 1, doi. 10.1111/appy.12548
- By:
- Publication type:
- Article
Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 1685, doi. 10.2147/NDT.S191803
- By:
- Publication type:
- Article
Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 2087, doi. 10.2147/NDT.S164673
- By:
- Publication type:
- Article
Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 1107, doi. 10.2147/NDT.S157399
- By:
- Publication type:
- Article
Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 825, doi. 10.2147/NDT.S158353
- By:
- Publication type:
- Article
Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study.
- Published in:
- Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 2045, doi. 10.2147/NDT.S131224
- By:
- Publication type:
- Article
Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study.
- Published in:
- Neuropsychiatric Disease & Treatment, 2015, v. 11, p. 1483, doi. 10.2147/NDT.S81760
- By:
- Publication type:
- Article
Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.
- Published in:
- 2018
- By:
- Publication type:
- journal article